EMBC 15.51 (-6%)
US29082K1051Drug ManufacturersDrug Manufacturers - Specialty & Generic

Embecta (EMBC) Competitor Comparison

We are evaluating the key criteria listed to compare Embecta (EMBC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Earnings per Share - EMBC ranking 7 / 54

These are the competitors of Embecta in the industry Drug Manufacturers - Specialty & Generic ranked by earnings per share
1. Linc LNC
9.52
2. Zoetis ZTS
5.09
3. Amphastar Pharmaceuticals AMPH
3.26
4. Collegium Pharmaceutical COLL
2.73
5. Taro Pharmaceutical Industries TARO
1.43
6. Pacira BioSciences PCRX
1.34
7. Embecta EMBC
1.2
8. ANI Pharmaceuticals ANIP
1.19
9. Alimera Sciences ALIM
1.05
10. Eagle Pharmaceuticals EGRX
0.85
11. Procaps Group PROC
0.51
12. Vifor Pharma G2AB.F
0.46
13. PetIQ PETQ
0.37
14. Kamada KMDA
0.27
15. Green Thumb Industries R9U2.F
0.25
16. Kolinpharma KIP.MI
0.21
17. Journey Medical DERM
0.13
18. Supernus Pharmaceuticals SUPN
0.09
19. Ironwood Pharmaceuticals IRWD
0.08
20. Phibro Animal Health PAHC
0.06
21. Organogenesis Holdings ORGO
-0.13
22. Theratechnologies THTX
-0.13
23. Societal CDMO SCTL
-0.14
24. Cronos Group CRON
-0.15
25. Ascend Wellness Holdings AAWH
-0.23
26. Curaleaf Holdings CURLF
-0.3
27. OptiNose OPTN
-0.31
28. Tilray Brands TLRY
-0.34
29. Regencell Bioscience Holdings RGC
-0.36
30. Teva Pharmaceutical Industries TEVA
-0.39
31. Jupiter Wellness JUPW
-0.59
32. Cumberland Pharmaceuticals CPIX
-0.72
33. SCYNEXIS SCYX
-0.74
34. Amneal Pharmaceuticals AMRX
-0.8
35. Perrigo PRGO
-0.83
36. Zynerba Pharmaceuticals ZYNE
-0.85
37. Evolus EOLS
-0.9
38. Alpha Teknova TKNO
-0.92
39. Harrow Health HROW
-0.95
40. Avadel Pharmaceuticals AVDL
-1.09
41. Bausch Health Companies BHC
-1.29
42. ProPhase Labs PRPH
-1.48
43. Universe Pharmaceuticals UPC
-1.7
44. Ayr Wellness 3KJB.F
-1.78
45. Elanco Animal Health ELAN
-2.55
46. Alvotech ALVO
-2.65
47. Relmada Therapeutics RLMD
-2.72
48. Solid Biosciences SLDB
-3.29
49. Catalent CTLT
-5.76
50. Flora Growth FLGC
-6.24
51. Biofrontera BFRI
-10.3
52. Emergent BioSolutions EBS
-11.22
53. Neoleukin Therapeutics NLTX
-12.28
54. Clever Leaves Holdings CLVR
-12.63

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.